Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers

NCT03522012 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Tocilizumab

Sponsor

Mycenax Biotech Inc.